Background and Purpose-There are no agreed measures of stroke care quality that enable the standardized comparison of stroke care between countries. We aimed to develop a set of measures of quality of acute stroke care involving stroke quality registers in Western Europe. Methods-A multinational working group identified 6 regional or national stroke quality registers in Europe and reviewed their data sets, performance measures, and the method by which these had been developed. Measures used in the registers were presented for discussion to a consensus group of representatives from the quality registers identified, as well as other stroke experts, and the final set of common performance measures was agreed through majority consensus. Results-Thirty final performance measures were agreed by the European consensus group, encompassing the domains of coordination of care (stroke unit-based care), diagnosis (brain imaging, vascular imaging, cardiac arrhythmia detection, and therapy assessment), preservation of neural tissue (thrombolytic therapy and door-to-needle time), prevention of complications (dysphagia screening), initiation of secondary prevention (antiplatelet, anticoagulation, lipid lowering, blood pressure lowering, carotid surgery, time from vascular imaging to carotid surgery, and smoking cessation), survival (90-day poststroke mortality), and functional outcomes (90-day modified Rankin Scale). Conclusions-On the basis of experience of quality registers in Europe, we have proposed a common set of performance measures that will facilitate the international comparison of acute stroke care quality. (Stroke. 2015;46:2891-2895.
I mproving the quality of care for people with acute stroke is an urgent issue for healthcare systems globally: stroke is one of the major causes of morbidity 1 and mortality 2 worldwide in adults and places a large burden on societies and individuals. 3 There is now a substantial evidence base for interventions effective in improving outcomes after stroke 4 and ensuring that patients have timely access to evidence-based interventions, which is an essential component of good quality care.
Many healthcare systems perform measurement of the quality of stroke care as a part of a process of quality improvement. As well as measuring and reporting on the quality of care in individual countries or regions, comparing the quality of care across different countries or health systems can provide a powerful insight into the performance of different healthcare systems, identify inequalities in care, and help to explain differences in healthcare outcomes. However, meaningful international comparisons of the quality of care are difficult because of a lack of standardized and commonly agreed measures of stroke care quality. 5 Therefore, we aimed to develop a harmonized set of healthcare performance measures that could be used for crossnational comparisons of the quality of acute stroke care. This was done as a part of an European project, exploring the implementation of evidence-based care into routine clinical practice.
Stroke
October 2015
Methods
The development of the indicators was led by a working group within the European Union-funded European Implementation Score project (No. 223153) comprised stroke physicians, neurologists, and public health academics. The working group first performed preparatory work, comprising the identification of stroke quality registers already established in Europe, documentation of the methods used in the registers to derive quality indicators, and listing of the data elements and indicators used in each register. 5 Quality registers active in Europe (non-European registers were not eligible because this was a project funded to support the implementation of evidence-based care in the European Union) were identified through literature review and personal communication and invited to participate; detailed methods have been described previously. 5 Six European stroke quality registers were reviewed by the working group: 4 Performance measures common to ≥4 of the registers were included in a set of performance indicators for consideration by a wider group of stroke experts. The European Implementation Score working group invited representatives (online-only Data Supplement) from the quality registers and other stakeholders active in European stroke quality registers on stroke to a consensus meeting, plus representatives from patient organizations (Lund, Sweden, April 2011). During the meeting, each of the indicators were presented and reviewed in plenary discussion. The discussion was facilitated to encourage involvement from all participants. The final indicators were chosen when there was agreement by majority consensus. In addition, measures that were not currently widely collected but that were considered to be valuable were also discussed for potential inclusion, using the same methods.
Indicators were specified at 2 levels (Tier I and Tier II), recognizing that the capacity to collect data varies between health systems and settings. Tier I indicators were those considered to be essential data items to be collected in all registers. Tier II indicators were those that would be desirable to collect but likely to be more challenging or resource intensive to collect and so were included as an extended set of quality indicators that should be collected if possible. Finally, the working group further detailed and refined the agreed set of indicators and thematically mapped them to the stroke quality domains proposed by the American Heart Association and American College of Cardiology. 9 The final consensus document was presented at the European Stroke Organization and endorsed by the general assembly on May 26, 2011, during the European Stroke Conference in Hamburg.
Results

Methods Used to Derive Quality Indicators in the Registers
The characteristics of the registers, including the method by which their quality indicators had been developed, have been described in detail previously. 5 The registers had commenced data collection between 1994 and 2007 (Sweden: 1994; England, Wales, and Northern Ireland: 1998; Germany: 1999; Scotland: 2002; Catalonia: 2005; and Flanders: 2007) and most used a prospective and continuous design for data collection. 5 The registers used a variety of methods to develop quality indicators, including use of multistakeholder and multiprofessional expert panels, systematic review of published literature, and consensus methods such as the modified Delphi method.
The German Stroke Registers Study Group methodology had previously been described in detail: an initial systematic literature review to identify areas of evidence-based practice, independent external evaluation of the proposed indicators, and prospective pilot study to evaluate the indicators in clinical practice. 6 Stakeholders (professions and organizations involved in acute stroke care, stroke societies, quality improvement organizations, and patient organizations) were involved by membership of the Quality Indicator Board of the German Stroke Registers Study Group, which provides governance for the register.
Multiprofessional involvement and stakeholder engagement in the development of quality indicators were also used by Catalonian Stroke Registry, the Sentinel stroke audit in the United Kingdom, Riks-Stroke, and the Scottish Stroke Care Audit.
Riks-Stroke in Sweden started with a limited number of indicators, which had subsequently been expanded over time. Indicator development was performed by consensus decisions from the Riks-Stroke Steering Committee, based on the development of new scientific evidence for different aspects of care, and aiming to monitor quality from different pointsof-view (eg, patients' perspective in addition to clinicians' perspectives).
Consensus Discussion and Final Decisions
The number of data items included in each of the quality registers ranged from 21 to >100 items. Thirty-four indicators were included in ≥2 of the registers, and 9 indicators were used in ≥4 of the registers. The 9 indicators used in ≥4 registers were in the domains of coordination of care (1 indicator), diagnosis (1 indicators), preservation of neural tissue (1 indicator), secondary prevention (4 indicators), prevention of complications (1 indicator), and restoration of function (1 indicator; Table 1 ) None of these indicators extended beyond the acute in-hospital episode, and none included patient-reported outcome measurement. Indicators on patients with transient ischemic attack 
Discussion
This is the first attempt to agree a common cross-national set of performance measures in stroke care. Given that the aim was to generate a consensus set of performance measures that were already being collected, one of the challenges in doing this were wide disparities in the variables collected in different health systems. 5 This proved to be a significant limitation in agreeing a common set of performance measures. It is striking the degree to which different healthcare systems prioritize different aspects of care quality: local contextual factors seem at least as important as the evidence base and the clinical characteristics of stroke in determining what measures are collected as performance measures in different healthcare systems. Nonetheless, the group was able to identify a set of 18 core performance indicators, 12 more advanced indicators, and 6 demographic data items that were either already widely collected in quality registers or considered by consensus to be desirable to be included in future data collections on stroke quality. The collection of these indicators will, if implemented, enable the systematic comparison of stroke quality between different healthcare systems in Europe.
In keeping with this finding, the set of performance measures agreed here share only some similarities with measures developed for use in other countries. In the United States, for example, there are many regional and national initiatives measuring the quality of stroke care. A review aiming to identify a harmonized set of performance measures for the United States identified 10 measures: of these, 7 are similar to indicators developed as a part of the current study (antithrombotic therapy, anticoagulation if in atrial fibrillation, thrombolytic therapy, lipid-lowering therapy, dysphagia screening, smoking cessation, and assessment for rehabilitation). 10 Measures suggested in the United States but not included in the current proposal included deep vein thrombosis prophylaxis and stroke education. Of the 23 acute care measures developed in the Canadian Stroke Quality of Care Study, stroke unit-based care, brain imaging and thrombolysis measures, carotid imaging, and secondary prevention measures were similar to the current indicators set. 11 A variety of other measures were suggested for Canada, but not in the current initiative, such as blood glucose monitoring and the use of antipyretics in febrile patients. 11 The development of quality indicators in stroke care builds on previous recommendations from a American Heart Association/American College of Cardiology working group outlining a systematic approach to measuring stroke care quality, encompassing structural measures (involvement in quality improvement, local competence, stroke care planning, provision of brain imaging, and access to neurosurgical expertise), process measures (patient care plans, clinical evaluation, acute therapy, secondary prevention, and functional assessment and rehabilitation), and patient-centered outcomes. 9 The American Heart Association working group stopped short of defining specific quality indicators, and implementation of quality indicators in subsequent years likely reflects developments in the evidence base for stroke care, greater availability of data on care quality, and greater experience in the development and the use of quality indicators. This work is also consistent with recent work by the World Stroke Organization to develop globally applicable performance measures for stroke care. It has recently published consensus guidelines describing the components of stroke services that should be provided, setting out a multilevel approach that takes into account the level of resource available in different health economies . 12 This includes a set of 26 quality indicators across 5 domains of care: hyperacute stroke care (ie, immediate care in the first hours and days, particularly in the short time window after stroke onset when revascularization is most effective), acute inpatient care, prevention of recurrent stroke, stroke rehabilitation, and community reintegration and recovery. 12 There are many reasons why collecting comparable data about healthcare quality across countries are challenging. Health systems and registers differ in their funding, organization, and level of resource, all of which may influence the methodology, frequency, and the use of data collection that they can achieve. Quality registers also have to manage competing demands for information from different users of the data; the data needs of policy makers or healthcare funders might be different to those of clinical teams, patients, and the general public. Keeping up with changes in evidence is also a challenge to maintaining consistency, and technical innovations such as telestroke, 13 and intra-arterial therapies 14 mean that registers have to evolve to ensure that they keep up to date with changes in evidence and practice. Quality registers need to be able to adapt quickly to innovations so that they continue to provide meaningful data on care quality and support the implementation of new evidence. These challenges are faced by all registers, and so the collection of comparable and consistent data on stroke care quality might, therefore, be the most successful as a part of an ongoing collaboration between registers. There are examples from outside stroke care that demonstrate the feasibility of such an approach, such as cancer care 15 and renal dialysis, 16 where national and regional registers contribute to Europe wide quality registers.
Such collaborations might also usefully extend beyond the agreeing data items and performance measures and facilitate learning and examples of good practice in tackling the challenges common to all quality registers, such as how to use data most effectively to support quality improvement in healthcare services. We hope that agreeing common performance measures will be a first step toward greater collaboration in the wider effort to improve the quality of stroke care across Europe.
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Conclusions
Despite the challenges posed by different health systems and data collections performed in the 6 European countries and regions included in this study, the group identified a set of 30 performance measures of acute stroke quality that were common to most of the quality registers and recognized by stakeholders to be important markers of quality of care. Agreeing these common performance measures for stroke quality is an important first step in allowing meaningful comparisons of care quality between different health systems.
